$CLS

MIONIS ROBERT sold $7.0M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 18,176 indirectly-held shares of CELESTICA INC (CLS) at an average of $385.17 ($378.37–$392.11, $7.00M total) across 14 trades on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Jun 18, 2026, 12:54 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

The disclosure provides a fresh, timestamped data point on insider activity. However, the stated Rule 10b5-1 pre-arranged plan suggests the sale schedule was predetermined, reducing the likelihood of a strong fundamental read-through.

02

Market read

A new Form 4 insider-sale print for CLS, but with 10b5-1 context that typically limits trading signal strength.

03

What to watch

Traders may over-weight the headline sale size; the key nuance is the plan being pre-arranged, which often limits interpretive edge.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-17 (after market) for a sale executed 2026-06-17

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS) by CEO Mionis Robert, executed across 14 trades on 2026-06-17.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $7.0M of CLS shares via a Rule 10b5-1 plan, with 18,176 shares sold on 2026-06-17.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is primary-source and time-stamped, but it is explicitly a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary sales.

Market effects

Minimal; this is company-specific insider activity with no stated operational/regulatory change.

Minimal; no cross-border transaction or macro linkage described.

Minimal; no global supply-chain or contract details provided.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than a bearish view on fundamentals.

Key entities

  • CELESTICA INC

    Issuer of the Form 4 insider sale; CEO Mionis Robert sold 18,176 shares for ~$7.0M.

  • MIONIS ROBERT

    Celestica CEO and director; sold shares via an open-market transaction under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.